E-LIB Suche - Ergebnisse für: Alfonso, Pilar

1

Olaparib with or without bevacizumab versus bevacizumab plu..:

Takashima, Atsuo ; García-Alfonso, Pilar ; Manneh, Raimundo...
European Journal of Cancer. 205 (2024) - p. 114036 , 2024

Link: https://doi.org/10.1016/..

2

Hypertension as predictive factor for bevacizumab-containin..:

Rodríguez-Lescure, Álvaro ; Gallego, Javier ; Garcia-Alfonso, Pilar...
Clinical and Translational Oncology. , 2024

Link: https://doi.org/10.1007/..

3

Sequential RAS mutations evaluation in cell-free DNA of pat..:

Valladares-Ayerbes, Manuel ; Safont, Maria José ; González Flores, Encarnación...
Clinical and Translational Oncology. , 2024

Link: https://doi.org/10.1007/..

4

Delphi consensus for the third-line treatment of metastatic..:

García-Alfonso, Pilar ; Vera, Ruth ; Aranda, Enrique..
Clinical and Translational Oncology. 26 (2024) 6 - p. 1429-1437 , 2024

Link: https://doi.org/10.1007/..

5

Cost-effectiveness of apixaban and rivaroxaban in thrombopr..:

Muñoz, Andrés J. ; Ortega, Laura ; Gutiérrez, Ana...
Journal of Medical Economics. 26 (2023) 1 - p. 1145-1154 , 2023

Link: https://doi.org/10.1080/..

6

An international comparative analysis and roadmap to sustai..:

Alnaqbi, Khalid A. ; Bellanger, Agnès ; Brill, Alex...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Fruquintinib versus placebo in patients with refractory met..:

Dasari, Arvind ; Lonardi, Sara ; Garcia-Carbonero, Rocio...
The Lancet. 402 (2023) 10395 - p. 41-53 , 2023

Link: https://doi.org/10.1016/..

8

Recommendations for the optimal management of peritoneal me..:

Grávalos, Cristina ; Pereira, Fernando ; Vera, Ruth...
Clinical and Translational Oncology. 25 (2023) 12 - p. 3378-3394 , 2023

Link: https://doi.org/10.1007/..

9

Post-Chemoradiation Metastatic, Persistent and Resistant No..:

Calvo, Felipe A. ; Tudela, María ; Serrano, Javier...
Cancers. 15 (2023) 18 - p. 4591 , 2023

Link: https://doi.org/10.3390/..

10

A randomised phase 2 study comparing different dose approac..:

Argilés, Guillem ; Mulet, Nuria ; Valladares-Ayerbes, Manuel...
European Journal of Cancer. 177 (2022) - p. 154-163 , 2022

Link: https://doi.org/10.1016/..

11

Evolution of RAS Mutations in Cell-Free DNA of Patients wit..:

Valladares-Ayerbes, Manuel ; Garcia-Alfonso, Pilar ; Muñoz Luengo, Jorge...
Cancers. 14 (2022) 24 - p. 6075 , 2022

Link: https://doi.org/10.3390/..

12

Upfront primary tumour resection and survival in synchronou..:

Benavides, Manuel ; Gómez-España, Auxiliadora ; García-Alfonso, Pilar...
European Journal of Surgical Oncology. 48 (2022) 5 - p. 1123-1132 , 2022

Link: https://doi.org/10.1016/..

13

Systematic review of randomised clinical trials and observa..:

García-Alfonso, Pilar ; Lièvre, Astrid ; Loupakis, Fotios...
Critical Reviews in Oncology/Hematology. 173 (2022) - p. 103646 , 2022

Link: https://doi.org/10.1016/..

14

Expert consensus of the Spanish Society of Pathology and th..:

Vera, Ruth ; Ibarrola-de-Andrés, Carolina ; Adeva, Jorge...
Clinical and Translational Oncology. 24 (2022) 11 - p. 2107-2119 , 2022

Link: https://doi.org/10.1007/..

15

Neoadjuvant therapy impact in early pancreatic cancer: "bio..:

Taboada, Alvaro Gregorio Morales ; Lominchar, Pablo Lozano ; Martínez, María Fernández...
Annals of Hepato-Biliary-Pancreatic Surgery. 26 (2022) 4 - p. 363-374 , 2022

Link: https://doi.org/10.14701..